Delivery Order SPE2DB22D3004-SPE2DB25FPM01
Award Date
2/11/25
Potential Completion Date
2/12/25
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $1,293.00 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the provision of 4565519574 - VYVANSE 50 MG CAPSULE 100S. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,982,057 units of VYVANSE 50 MG CAPSULE 100S. The award, valued at $2,616.61, has an ultimate completion date of March 18, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,801.92, is for the delivery of VYVANSE 60 MG CAPSULE 100S, a medication. The contract has a firm fixed price pricing type and a completion date of January 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 100 units of the pharmaceutical product VYVANSE 50 MG CAPSULE. The contract has a ceiling value of $2,568.66 and a period of performance through April 4, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which has a potential value of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VYVANSE 20 MG CAPSULE 100S. The total ceiling value of the contract is $1,535.33 and the ultimate completion date is April 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp with a potential value of up to $999,999,999.00 and a...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide the U.S. federal government with VYVANSE 50 MG CAPSULE 100S. The fixed-price contract, valued at $2,213.32, has a completion date of June 3, 2024. This award is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,435,383 units of the medication VYVANSE 30 MG CAPSULE 100S, with a ceiling value of $2,304.95. The contract is a firm fixed-price delivery order with an ultimate completion date of November 15, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
The U.S. Defense Logistics Agency (DLA) awarded a $2,839.26 firm fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division for the supply of 100-count bottles of VYVANSE 40 mg capsules. This order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive range of pharmaceutical and medical supplies to support...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,110.55 firm fixed-price contract is for the supply of VYVANSE 70 MG CAPSULE 100S, a pharmaceutical product. The award has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VYVANSE 50 MG CAPSULE 100S. The contract has a firm fixed price of $1,724.00 and an ultimate completion date of July 31, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which AmerisourceBergen holds with the DLA Troop Support Medical...